PRESS BOX
MORE IR NEWS
Release according to art. 93 section 2 BörseG
Managers' transactions announcement according to article 19 MAR
Managers' transactions announcement according to article 19 MAR
Medigene collaborates with RXi Pharmaceuticals to further sharpen its therapeutic T cells
Release of capital market information
Managers' transactions announcement according to article 19 MAR
Managers' transactions announcement according to article 19 MAR
 
ANNOUNCEMENT OF 10.05.2017 10:20 AM
Meldung drucken Artikel weiterleiten
pta20171005015
Managers' transactions announcement according to article 19 MAR
Pressefach Pressefach

3U HOLDING AG: Managers' transactions announcement according to article 19 MAR

Marburg (pta015/05.10.2017/10:20) - Announcement

1 Details of the person discharging managerial responsibilities/person closely associated
a) Name Jürgen Beck-Bazlen
2 Reason for the notification
a) Position/status Member of the Supervisory Board
b) Initial notification
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name 3U HOLDING AG
b) LEI 529900VVQ4470YJ67K26
4 Details of the transaction(s)
a) Description of the financial instrument, type of instrument Share
Identification code DE0005167902
b) Nature of the transaction Purchase
c) Price(s) Volume(s)
EUR 0.808 EUR 29,016.30
EUR 0.812 EUR 3,249.04
EUR 0.813 EUR 2,519.12
EUR 0.861 EUR 5,403.38
EUR 0.862 EUR 2,342.82
EUR 0.852 EUR 6,813.93
d) Aggregated price Aggregated volume
EUR 0,822 EUR 49.344,59
e) Date of the transaction 02.10.2017 UTC+2
f) Place of the transaction Systematic internalization by Consorsbank

(end)

emitter: 3U HOLDING AG
Frauenbergstraße 31-33
35039 Marburg
Germany
contact person: Peter Alex
phone: +49 6421 999-1200
e-mail:
website: www.3u.net
ISIN(s): DE0005167902 (share)
stock exchanges: regulated market in Frankfurt, Tradegate; free market in Dusseldorf, free market in Hamburg, free market in Munich, free market in Stuttgart; open market in Berlin
3U HOLDING AG